These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7072414)

  • 21. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
    Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leucine aminopeptidase activity in cerebrospinal fluid.
    Santhanagopalan T; Joseph HA
    Indian J Pathol Bacteriol; 1967 Apr; 10(2):144-9. PubMed ID: 6041969
    [No Abstract]   [Full Text] [Related]  

  • 24. [Relation between the clinical and cerebrospinal fluid parameters in multiple sclerosis, with special reference to subjects without oligoclonal IgG in the cerebrospinal fluid].
    Poloni M; Rocchelli B; Mazzarello P; Delodovici M
    Riv Neurol; 1981; 51(2):69-80. PubMed ID: 7244541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Magnetic Resonance Imaging study of the role of the blood-brain barrier in the pathogenesis of experimental allergic encephalomyelitis: application to multiple sclerosis].
    Chambron J; Namer IJ; Steibel J; Gounot D; Armspach JP
    Bull Acad Natl Med; 1994 Dec; 178(9):1647-63; discussion 1663-5. PubMed ID: 7788436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A; Toledo EG; Alexander JS; Kelley RE
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G; Balesar R
    Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.
    Calabrese V; Raffaele R; Cosentino E; Rizza V
    Int J Clin Pharmacol Res; 1994; 14(4):119-23. PubMed ID: 7607784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced levels of mitochondrial enzyme 17beta-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis.
    Kristofiková Z; Bocková M; Hegnerová K; Bartos A; Klaschka J; Rícný J; Rípová D; Homola J
    Mol Biosyst; 2009 Oct; 5(10):1174-9. PubMed ID: 19756307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topographic analysis of MS and control brains.
    Röyttä M; Frey H; Riekkinen P; Rinne UK
    Adv Exp Med Biol; 1978; 100():569-83. PubMed ID: 211829
    [No Abstract]   [Full Text] [Related]  

  • 31. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity.
    Minohara M; Matsuoka T; Li W; Osoegawa M; Ishizu T; Ohyagi Y; Kira J
    J Neuroimmunol; 2006 Sep; 178(1-2):156-60. PubMed ID: 16839613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute myelopathies in young patients and multiple sclerosis. prospective study of 20 cases].
    Dalecky A; Pelletier J; Chérif AA; Lévrier O; Khalil R
    Rev Neurol (Paris); 1997 Oct; 153(10):569-78. PubMed ID: 9684021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of spinal cord imaging in the diagnosis of multiple sclerosis.
    Nielsen JM; Barkhof F; van Oosten BW; Polman CH
    Nat Clin Pract Neurol; 2006 May; 2(5):283-6; quiz 287. PubMed ID: 16932565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
    Abo-Krysha N; Rashed L
    Mult Scler; 2008 Jun; 14(5):602-8. PubMed ID: 18408021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Leucine aminopeptidase activity in the cerebrospinal fluid in nervous system diseases].
    Buchinger W; Hohenegger M
    Wien Klin Wochenschr; 1969 Dec; 81(50):920-1. PubMed ID: 5380795
    [No Abstract]   [Full Text] [Related]  

  • 37. Caspase-1 levels in biological fluids from patients with multiple sclerosis and from patients with other neurological and non-neurological diseases.
    Franciotta D; Martino G; Zardini E; Furlan R; Bergamaschi R; Gironi M; Bergami A; Angelini G; De Benedetti F; Pignatti P; Moscato G; Cosi V
    Eur Cytokine Netw; 2002; 13(1):99-103. PubMed ID: 11956027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Observations on clinical significance of leucine-aminopeptidase activity of the blood].
    Meoni S; Meschino S; Scalise G; Massari F
    Minerva Med; 1965 Oct; 56(79):3361-4. PubMed ID: 5321261
    [No Abstract]   [Full Text] [Related]  

  • 39. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid.
    Gontsarova A; Kaufmann E; Tumani H; Dressel A; Mandel F; Wiesmüller KH; Kunert-Keil C; Brinkmeier H
    Clin Chim Acta; 2008 Mar; 389(1-2):152-9. PubMed ID: 18187042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.